Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by SNIPR BIOME
Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases
August 12, 2026
From
SNIPR BIOME
Via
GlobeNewswire
SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe
March 03, 2026
From
SNIPR BIOME
Via
GlobeNewswire
SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance
August 07, 2025
From
SNIPR BIOME
Via
GlobeNewswire
SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer
June 12, 2025
From
SNIPR BIOME
Via
GlobeNewswire
SNIPR Biome Strengthens IP Portfolio with Patent Granted for a Novel CRISPR-Cas System
February 24, 2025
From
SNIPR BIOME
Via
GlobeNewswire
SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women
June 28, 2024
From
SNIPR BIOME
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.